AngioDynamics (STU:UG2) Total Liabilities: €82.5 Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:UG2 AngioDynamics Inc STU:UG2
64 GF Score
Price €11.80
GF Value €8.32
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is AngioDynamics Total Liabilities?

AngioDynamics STU:UG2 -3.28% 64 Total Liabilities is €82.5 Mil as of May. 2026. GuruFocus rates STU:UG2 with a GF Score™ of 64/100 and a GF Value™ of €8.32 (Significantly Overvalued). The stock has 6 warning signs investors should review.

AngioDynamics's Total Liabilities for the quarter that ended in May. 2026 was €82.5 Mil.

AngioDynamics's quarterly Total Liabilities declined from Nov. 2025 (€80.75 Mil) to Feb. 2026 (€73.87 Mil) but then increased from Feb. 2026 (€73.87 Mil) to May. 2026 (€82.47 Mil).

AngioDynamics's annual Total Liabilities declined from May. 2024 (€103.68 Mil) to May. 2025 (€86.19 Mil) and declined from May. 2025 (€86.19 Mil) to May. 2026 (€82.47 Mil).

AngioDynamics Total Liabilities Historical Data

* Premium members only.

The historical data trend for AngioDynamics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioDynamics Total Liabilities Chart

AngioDynamics Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 121.34 141.99 103.68 86.19 82.47

AngioDynamics Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.19 74.55 80.75 73.87 82.47
STU:UG2
64GF Score
AngioDynamics Inc STU:UG2
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AngioDynamics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

AngioDynamics's Total Liabilities for the fiscal year that ended in May. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=63.958+(0+13.957
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+4.55+0+0)
=82.5

Total Liabilities=Total Assets (A: May. 2026 )-Total Equity (A: May. 2026 )
=228.692-146.226
=82.5

AngioDynamics's Total Liabilities for the quarter that ended in May. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=63.958+(0+13.957
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+4.55+0+0)
=82.5

Total Liabilities=Total Assets (Q: May. 2026 )-Total Equity (Q: May. 2026 )
=228.692-146.226
=82.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €82.5 Mil mean?
AngioDynamics (STU:UG2) has a Total Liabilities of €82.5 Mil as of May. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for AngioDynamics and its competitors.
Is AngioDynamics' Total Liabilities too high?
AngioDynamics' current Total Liabilities is €82.5 Mil. Overall, AngioDynamics has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AngioDynamics' Total Liabilities compare to NNNN and OSUR?
AngioDynamics' Total Liabilities of €82.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for AngioDynamics and its competitors. AngioDynamics's current Total Liabilities is €82.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AngioDynamics stock overvalued right now?
Based on GuruFocus' analysis, AngioDynamics (STU:UG2) is currently considered Significantly Overvalued. The stock's GF Value™ is €8.32, compared to a current price of €11.80 — trading 41.8% above its estimated fair value. The current Total Liabilities is €82.5 Mil. AngioDynamics' overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For AngioDynamics (STU:UG2), the current Total Liabilities is €82.5 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AngioDynamics (STU:UG2) Overvalued in 2026?

Based on GuruFocus' analysis, AngioDynamics stock appears to be overvalued. The current stock price of €11.80 is trading 41.8% above its estimated GF Value™ of €8.32. GuruFocus considers AngioDynamics to be Significantly Overvalued.

Key valuation signals for STU:UG2:

  • Total Liabilities: €82.5 Mil
  • GF Value™: €8.32 vs. price of €11.80 (41.8% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the STU:UG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AngioDynamics Business Description

Other Exchanges ANGO:USA
Address 14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
64GF Score

Get the complete analysis for STU:UG2

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.80
Price
€8.32
GF Value